Stay updated on Atezolizumab vs Durvalumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:52:31.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the detailed study purpose and inclusion/exclusion criteria for a clinical trial on non-small cell lung cancer (NSCLC). Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    14%
    Check dated 2025-04-16T14:44:39.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 7, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.1%
    Check dated 2025-04-09T10:01:09.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:35:03.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a decrease in the number of study locations from 199 to 178, with significant additions of new locations in various countries, including the United States, Brazil, China, and several European nations.
    Difference
    28%
    Check dated 2025-03-11T04:43:45.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.7%
    Check dated 2025-02-24T21:05:48.000Z thumbnail image

Stay in the know with updates to Atezolizumab vs Durvalumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.